Browse by author
Lookup NU author(s): Professor Graham Jackson, Dr Penelope Taylor, Dr Anne Lennard, Professor Stephen Proctor
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
There has been a great deal of interest in the use of high dose chemotherapy and/or radiotherapy, with autologous bone marrow/peripheral blood stem cell rescue, in the treatment of haematological malignancies including acute lymphoblastic leukaemia (ALL). In this review we assess the role of autologous bone marrow transplantation (ABMT) in ALL. The heterogeneity of this disease makes the analysis of treatment results in ALL difficult to interpret. There is some evidence that ABMT may be useful in second complete remission (CR) and increasing interest in ABMT as a therapeutic option in first CR in adults. At the moment there is little evidence that such an approach will have an impact in childhood ALL. ABMT is considerably less toxic than allogeneic bone marrow transplantation and the major cause of 'treatment failure' is disease relapse. There has been considerable effort put into purging autologous bone marrow of malignant stem cells but whether purging is effective remains controversial and not proven. Newer studies involving cytokines post-ABMT to stimulate an artificial 'graft versus leukaemia' effect may prove of value.
Author(s): Jackson, G. H., Taylor, P. R. A., Lennard, A. L., Proctor, S. J.
Publication type: Article
Publication status: Published
Journal: Blood Reviews
Year: 1994
Volume: 8
Issue: 3
Pages: 161-168
Print publication date: 01/09/1994
ISSN (print): 0268-960X
ISSN (electronic): 1532-1681
URL: http://dx.doi.org/10.1016/0268-960X(94)90077-U
DOI: 10.1016/0268-960X(94)90077-U
Altmetrics provided by Altmetric
